Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radiobiology

  • You have access
    Dosimetry for Radiopharmaceutical Therapy: The European Perspective
    Michael Lassmann, Uta Eberlein, Jonathan Gear, Mark Konijnenberg and Jolanta Kunikowska
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 73S-79S; DOI: https://doi.org/10.2967/jnumed.121.262754
  • You have access
    Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
    Price A. Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo and John Violet
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 1030-1036; DOI: https://doi.org/10.2967/jnumed.119.233411
  • You have access
    Prediction of Tumor Control in 90Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics
    Yuni K. Dewaraja, Theresa Devasia, Ravi K. Kaza, Justin K. Mikell, Dawn Owen, Peter L. Roberson and Matthew J. Schipper
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 104-111; DOI: https://doi.org/10.2967/jnumed.119.226472
  • You have access
    The Relevance of Dosimetry in Precision Medicine
    Michael Lassmann and Uta Eberlein
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1494-1499; DOI: https://doi.org/10.2967/jnumed.117.206649
  • You have access
    First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
    Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
    Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010
  • You have access
    Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
    Uta Eberlein, Marta Cremonesi and Michael Lassmann
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire